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We have studied the relationship between insulin activation of insulin-receptor kinase and insulin stimulation of glucose 
uptake in isolated rat adipocytes. Glucose uptake was half-maximally or maximally stimulated, respectively, when only 
4% or 14% ofthe maximal kinase activity had been reached. To investigate this relationship also under conditions where 
the insulin effect on activation of receptor kinase was decreased, the adipocytes were exposed to 10 ,uM-isoprenaline alone 
or with 5,ug of adenosine deaminasejml. An approx. 30 % (isoprenaline) or approx. 50 % (isoprenaline + adenosine 
deaminase) decrease in the insulin effect on receptor kinase activity was found at insulin concentrations between 0.4 and 
20 ngjml, and this could not be explained by decreased insulin binding. The decreased insulin-effect on kinase activity was 
closely correlated with a loss of insulin-sensitivity of glucose uptake. Moreover, our data indieate that the relation between 
receptor kinase activity and glucose uptake (expressed as percentage of maximal uptake) remained unchanged. The 
following conclusions were drawn. (I) If activation of receptor kinase stimulates glucose uptake, only 14 % of the maximal 
kinase activity is sufficient for maximal stimulation. (2) Isoprenaline decreases the coupling efficiency between insulin 
binding and receptor-kinase activation, this being accompanied by a corresponding decrease in sensitivity of glucose 
uptake. (3) Our data indicate that the signalling for glucose uptake is closely related to receptor-kinase activity, even when 
the coupling efficiency between insulin binding and kinase activation is altered. They thus support the hypothesis that 
receptor-kinase activity reflects the signal which originates from the receptor and which is transduced to the glucose-
transport system. 
INTRODUCTION 
The insulin receptor is a transmembrane glycoprotein 
composed of two cx-subunits of 135 kOa and two ß-subunits of 
95 kOa [1,2]. Insulin binding to the cx-subunits causes rapid 
phosphorylation oftyrosine residues on the ß-subunits [1,3]. The 
phosphorylation of tyrosine-containing sites on the receptor in 
turn activates the insulin-receptor kinase toward tyrosine residues 
of other protein substrates [4-6]. Severallines of evidence indicate 
that autophosphorylation and activation of the insulin receptor 
as a tyrosine kinase is an important early step necessary for 
the transduction of many, if not all, of the biologieal effects of 
insulin [1,7,8]. A decreased ability of insulin receptors to auto-
phosphorylate or to activate their kinase in response to insulin 
could therefore cause or contribute to insulin resistance. In fact, 
a decreased kinase activity of insulin receptors has been found in 
a variety of situations where the effects of insulin on biological 
actions are decreased [9-14], including type-lI diabetes [15-17]. 
For technical reasons it has, however, so far been difficult to 
relate directly alterations in the coupling between insulin binding 
and insulin-induced activation of receptor kinase to alterations 
in biological actions such as glucose uptake. Firstly, in most 
studies, receptor kinase was not activated by stimulating intact 
cells with insulin, as was the case when biological actions were 
measured. Instead, receptors were first isolated, and only sub-
sequently stimulated in vitro by insulin. The results may therefore 
not reflect the situation in the intact cell. Secondly, owing to the 
marked rightward shift of the concentration-response curve for 
insulin activation of receptor kinase compared with those for the 
major biological effects ofinsulin, it has been difficult to measure 
the kinase activity in an insulin concentration range where 
changes in insulin concentration lead, for example, to changes in 
glucose transport. 
The aim of the present paper was to study the relationship 
between receptor kinase activity and glucose uptake at insulin 
concentrations which are sub-maximal or maximal for the 
stimulation of glucose uptake. Moreover, this relationship should 
be investigated under conditions where the coupling efficiency 
between insulin binding and activation of receptor kinase was 
altered. A highly sensitive assay to measure activation of insulin-
receptor kinase in intact rat adipocytes was developed, such that 
insulin activation of receptor kinase, as weil as 3-0-methylglucose 
uptake, could be measured under similar conditions and at 
similar insulin concentrations. Conditions with a decreased 
coupling efficiency between insulin binding and activation of 
receptor kinase were induced by preincubating the adipocytes 
with isoprenaline alone or together with adenosine deaminase 
(an enzyme which removes adenosine spontaneously released by 
isolated adipocytes from the incubation medium [18,19]). With 
this approach we tested the hypo thesis that the signalling for 
glucose uptake is correlated with receptor-kinase activity rather 
than receptor occupancy under these conditions. In addition, we 
investigated how a decreased coupling efficiency between insulin 
binding and activation of receptor kinase may influence glucose 
uptake. 
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MATERIALS AND METIlODS 
Materials 
Pig monocomponent insulin was from Novo Biolabs 
(Bagsvaerd, Denmark) and [1251_ TyrA14]monoiodoinsulin from 
Amersham (Braunschweig, Germany). Serum from a patient 
with anti-insulin-receptor antibodies [20] was kindly supplied by 
Dr. Lawrence Mandarino (Pittsburgh, PA, U.S.A.). [y_32P]ATP 
(5000 Ci/mmol) and 3-0-methylglucose were purchased from 
New England Nuclear (Dreieich, Germany). Collagenase, BSA 
and histone 2B were from Boehringer Mannheim (Mannheim, 
Germany). Materials for SDS/PAGE were from Bio-Rad 
(München, Germany). D-Isopropylarterenol was from Serva 
(Heidelberg, Germany), and all other reagents were purchased 
from Sigma (München, Germany). 
Isolation and incubation of cells 
Adipocytes were prepared by collagenase digestion [21] of 
epididymal fat-pads from male Sprague-Dawley rats (150-180 g) 
fed ad [ibo as described previously [19]. Incubations of the cells 
for measurement of insulin binding, 3-0-methylglucose uptake 
and activation of insulin-receptor kinase were performed under 
identical conditions. The cells were suspended in a buffer 
containing 128 mM-NaCl, 5.2 mM-KCl, 1.2 mM-CaCls, 1.3 mM-
KH2P04, 1 mM-Na2HP04, 40 mM-Hepes, 3 mM-D-glucose and 
2 % BSA, pH 7.4. Cell concentration was (0.8-1.6) x 105cells/ml, 
temperature 37°C, and the shaking speed 60/min in a rotatory 
water-bath. The cells were first incubated for 30 min at 37°C 
in the absence or presence of 10 pM-isoprenaline. In some 
experiments, other substances (5 pg of adenosine deaminase/ml, 
30 pM-propranolol or 1 pM-N'-phenylisopropyladenosine) were 
added alone or in addition to isoprenaline. Subsequently, 
different amounts ofinsulin were added for an additional 15 min 
in order to measure insulin binding (mono[125I]iodoinsulin), to 
activate the insulin-receptor kinase, or to stimulate glucose 
uptake, respectively. 
Insulin binding to intact cells 
This was determined with 0.2 ng of 1251-insulin/ml and 
increasing concentrations of unlabelled insulin as previously 
described [19]. Incubations were ended after 15 min by separating 
the cells from the incubation buffer [19,22]. 
Activation of insulin-receptor kinase in intact cells 
Measurement ofinsulin-receptor kinase activity after exposure 
of intact cells to insulin was performed essentially as previously 
described [19,23]; however, some modifications were introduced 
to increase the sensitivity of the assay. After incubation ,vith 
insulin, cells were solubilized under conditions designed to 
preserve the phosphorylation state of the receptors as it existed 
in the intact cell [6,19,23]. This was achieved by addition of 
kinase, phosphatase and protease inhibitors during solubilization 
(1 % Triton X-100, 2.5 mM-phenylmethanesulphonyl fluoride, 
800 trypsin-inhibitor units of aprotinin/ml, 8 mM-EDTA, 
160 mM-NaF, 10 mM-sodium pyrophosphate, 0.2 mM-sodium 
vanadate, 2 mM-dichloroacetic acid and 20 mM-Hepes, pH 7.4) 
and during partial purification of insulin receptors on wheat-
germ agglutinin-agarose (0.05 % Triton X-100, 100 mM-NaCl, 
2.5 mM-KCl, 1 mM-CaCI2, 0.1 mM-sodium vanadate, 100 mM-
NaF, 10 mM-sodium pyrophosphate, 4 mM-EDT A, 10% glycerol 
and 20 mM-Hepes, pH 7.4). The insulin-binding activities of the 
wheat-germ agglutinin-agarose eluates were measured as pre-
viously described [11,19], and if necessary binding activities were 
adjusted by dilution. SampIes of the eluates were then incubated 
for 16 h at 4°C with Sepharose bearing anti-(insulin-receptor) 
antibody. At the end ofthis incubation period, 94-100% ofthe 
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insulin receptors were bound to the antibody-Sepharose (as 
measured in control experiments using 32P-labelled receptors). 
Isoprenaline and/or insulin had no effect on insulin-receptor 
binding to the antibody-Sepharose. The Sepharose was washed 
five times in buffer containing 0.05 % Triton X-100, 100 mM-
NaCl, 2.5 mM-KCl, 1 mM-CaCI2, 0.1 mM-sodium vanadate and 
20 mM-Hepes, pH 7.4, and resuspended in 30 pI of the same 
buffer. Phosphorylation assays were performed by addition of a 
mixture to give final concentrations of 5 mM-MnCI2, 12 mM-
MgCI2, 500 pM-CTP, 1 mg ofhistone 2B/ml and 0.5 pM_[32P]A TP 
(100-200 Ci/mmol). After 6 min at 4°C (phosphate incorpor-
ation into histone was linear for more than 20 min), reactions 
were terminated by adding Laemmli buffer [24] and heating to 
95°C for 5 min [19]. Phosphorylated proteins were analysed by 
SDS/PAGE on 15 %-acrylamide gels. 
3-O-Methylglucose uptake 
Glucose uptake was assayed by measuring initial rates of 3-0-
methylglucose influx after rapid concentration of the cells 
(to '" 108 cells/ml) by centrifugation at the end ofthe incubations 
with insulin. All data presented are measurements of zero-trans 
influx, which was measured in quadruplicate determinations by 
a modification of the method of Whitesell & Gliemann [25]. The 
portion of cellular uptake owing to diffusion and trapping of the 
label in the extracellular space was measured by performing 
parallel reactions with L-[1-14C]glucose as substrate. All results 
for glucose uptake are corrected for the L-glucose value. 
Cellular A TP 
This was measured by a modification of an established method 
[26]. Briefly, 50 pi of the incubation medium containing '" 5000 
cells was added to 100 pi of ice-cold 10 % trichloroacetic acid 
and 0.15% of the detergent SBI4. Sampies were immediately 
vortex-mixed, and after 5 min then centrifuged. Then 20 pI ofthe 
supematant was added to 500 pI of 0.1 M-Tris/KOH buffer 
(pH 8), and the ATP content was rapidly measured with luciferase 
reagent. 
RESULTS 
Effect of isoprenaline alone or plus adenosine deaminase on 
insulin binding 
In the absence of adenosine deaminase, isoprenaline (10 pM) 
had no effect on insulin binding to the adipocytes (Fig. 1). Only 
when adenosine deaminase (5 pg/ml) was added in addition to 
isoprenaline, a small decrease of insulin binding ( '" 20 %) was 
observed. As alterations in the pH ofthe incubation medium can 
influence insulin binding, we have measured the pH of the 
medium at the end of the incubations. Under the three different 
conditions, the pH fell from 7.4 at the beginning of the 
incubations to 7.38±0.01 (no additions), 7.37±0.01 
(isoprenaline) and 7.35 ±0.01 (isoprenaline and adenosine 
deaminase). 
Insulin binding to wheat-germ-agglutinin-purified insulin 
receptors extracted from cells incubated with or without 
isoprenaline (or isoprenaline+adenosine deaminase) was also 
measured. No effect of isoprenaline or adenosine deaminase on 
the number or insulin affinity of the receptors was found (results 
not shown). 
Effect of isoprenaline alone or plus adenosine deaminase on 
insulin-dependent activation of insulin-receptor kinase in 
intact cells 
The effect of incubation of the cells with insulin on activation 
of insulin-receptor kinase is shown in Figs. 2(a) and 2(b). This 
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Fig. l. Effect of isoprenaline (alone or plus adenosine deaminase) on insulin 
binding to isolated adipocytes 
Adipocytes were incubated for 30 min in the absence (e) or pres-
ence of isoprenaline alone (A) or plus adenosine deaminase (.) 
as described in the Materials and methods section. SubsequentIy 
125I-insulin (0.2 ngjml) and unlabelled insulin at the indicated 
concentrations were added and incubations continued for 15 min. 
Incubations were ended by separating the cells from the incubation 
buffer as previously described [22]. The values are corrected for non-
specific binding and represent the means±s.E.M. of 12 independent 
experiments with triplicate determinations. 
incubation of the cells stimulated insulin-receptor kinase - 25-
fold, and the low background allowed measurements at insulin 
concentrations as low as 0.4 ng/m!. Insulin activation of insulin-
receptor kinase was significantly decreased by isoprenaline at all 
sub-maximal insulin concentrations measured (P < 0.05; Student 
paired t test). In the presence of isoprenaline, approximately 
twice the insulin concentration was necessary to evoke similar 
kinase activities as in the absence of isoprenaline. This effect of 
isoprenaline was more pronounced when adenosine was depleted 
from the medium with adenosine deaminase (Fig. 2b). To test the 
specificity of the effect of isoprenaline and adenosine deaminase, 
propranolol (30,uM) or N6-phenylisopropyladenosine (1 ,uM) 
respectively were added in addition to isoprenaline or adenosine 
deaminase in some experiments. Propranolol abolished the effects 
of isoprenaline, and N6-phenylisopropyladenosine (an adenosine 
analogue that is not deaminated by adenosine deaminase) the 
effects of adenosine deaminase (results not shown). 
Effect of isoprenaline alone or plus adenosine deaminase on 3-0-
methylglucose uptake 
The data in Fig. 3 show that isoprenaline led to a decrease in 
the maximal insulin effect on 3-0-methylglucose uptake as weil 
as to a shift to the right of the concentration-response curve 
[ECso (half-maximally effective concn.) 0.4 or 0.6 ng of insulin/mi 
in the absence or presence of isoprenaline respective1y). Under 
conditions where adenosine was depleted fromthe incubation 
buffer by adenosine deaminase, these effects of isoprenaline werc 
more pronounced (ECso I ng of insulin/mi). 
Relationship between insulin-receptor kinase activity and glucose 
uptake 
The concentration-response curves for activation of receptor 
kinase and for glucose uptake were quite different. Although 
3-0-methylglucose uptake was already maximal at an insulin 
concentration of I ng/ml (Fig. 3, e), activation of insulin-
receptor kinase at this concentration accounted for only 14 % of 
the maximum (Fig. 2b, e). To investigate the relationship 
between receptor-kinase activity and glucose uptake further, 
insulin stimulation of glucose uptake (expressed as percentage of 
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Fig. 2. Insulin activation of insulin-receptor kinase in intact adipocytes 
after incubation in the absence (e) or presence of isoprenaline alone 
(A) or pllL'l adenosine deaminase (.) 
Adipocytes were incubated for 30 min with or without the indicated 
substances under the same conditions as for the measurement of 
insulin binding. Subsequently insulin (0-500 ngjml) was added and 
incubations continued for 15 min. At the end of incubations, cells 
were rapidly solubilized in the presence of protease, kinase and 
phosphatase inhibitors. Insulin-receptor kinase activity was 
measured as described in the Materials and methods section. (a) An 
autoradiograph showing phosphorylation of histone 28 (H28) in a 
representative experiment (95 K : phosphorylated 95 kDa p-subunit 
ofinsulin receptor). (b) Dose-response curves for insulin activation 
of insulin-receptor kinase in intact cells. The values represent 
means±s.E.M. of 5-10 independent experiments with duplicate 
determinations. 
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Fig. 3. Insulin stimulation of 3-O-methylglucose uptake in adipocytes after 
incubation in the absence (e) or presence of isoprenaline a10ne (A) 
or pllL'l adenosine deaminase (.) 
Adipocytes were incubated for 30 min with or without isoprenaline 
alone or plus adenosine deaminase, as described above. SubsequentIy 
insulin was added at the indicated concentrations, and incubations 
continued for 15 min. Initial rates of 3-0-methylglucose uptake 
were determined as specified in the Materials and methods section. 
Data represent means of quadruplicate determinations ± S.E.M. of 5 
individual experiments. 
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Fig. 4. Relation between activity of re«ptor kinase and glucose uptake 
(a) Comparison of the effects of insulin to activate insulin-receptor 
kinase and to stimulate glucose uptake. In this Figure, the data for 
insulin-stimulated glucose uptake are shown as percentages of the 
maximal glucose uptake (e, no additions; .A., in the presence of 
isoprenaline; ., in the presence of isoprenaline + adenosine 
deaminase). Additionally, the lower part of the dose-response curve 
for insulin activation of insulin-receptor kinase is depicted (0, no 
additions: b,., in the presence ofisoprenaline; 0, in the presence of 
isoprenaline and adenosine deaminase). Data represent the mean 
values of results obtained in the same experiments as shown in Figs. 
2 and 3. (b) Data for insulin-stimulated glucose uptake (expressed as 
percentage ofthe maximal uptake) are plotted against the activity of 
receptor kinase measured under similar conditions (e, no additions; 
.A., with isoprenaline; ., with isoprenaline + adenosine deaminase) 
and similar insulin concentrations (0.4, land 4 ng/ml). Values 
represent means ± S.E.M. 
the maximal effect) and insulin activation of receptor kinase are 
depicted together in Fig. 4(a). The data show that similar kinase 
activities correspond to similar glucose uptake (expressed as 
percentage of maximal transport) under all conditions tested. 
For example, at a kinase activity of 18 fmol/min per pmol 
binding capacity a 50 % stimulation of glucose uptake is 
observed, regardless ofwhether 0.4, 0.6 or 1.0 ng ofinsulin/ml is 
necessary to elicit this kinase activity in control cells, isoprenaline-
treated cells or cells treated with isoprenaline and adenosine 
deaminase respectively. At a kinase activity of - 40 fmoljmin 
per pmol maximal glucose uptake is reached under all conditions 
tested. The data indicate that the relation between insulin-
receptor kinase activity and glucose uptake (the latter expressed 
as percentage ofmaximal glucose uptake) remains constant, even 
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under conditions where the coupling efficiency between insulin 
binding and activation of insulin-receptor kinase is altered. This 
is also demonstrated in Fig. 4(b), where glucose-uptake data are 
plotted against receptor-kinase activity. 
Effect of isoprenaHne alone or plns adenosine deaminase on 
ceUular ATP levels 
Because alterations in cellular ATP concentration may 
inftuence insulin activation of insulin-receptor kinase, cellular 
A TP levels were measured at the end of the incubations in four 
independent experiments. The data showed that A TP levels were 
slightly decreased by the incubations with isoprenaline alone or 
together with adenosine deaminase. In the absence of insulin, 
ATP concentrations were 771 ± 133, 738±43 and 712±92 
pmol/l05 adipocytes respectively, with no additions, or in the 
presence of isoprenaline alone or together with adenosine 
deaminase. In the presence of insulin (500 ng/ml), ATP 
concentrations were 802 ± 95, 680 ± 59 and 659 ± 58 pmol/ 1 05 
adipocytes respectively under the three conditions. 
DISCUSSION 
In the present study, concentration-response curves for insulin 
activation of insulin-receptor tyrosine kinase and for insulin 
activation of glucose uptake in isolated rat adipocytes have been 
compared. Dur data show that if activation of insulin-receptor 
kinase represents the intracellular signal which leads to a 
stimulation of glucose uptake, only 14 % of the maximal kinase 
activity is sufficient for a maximal stimulation (Figs. 2b and 3). 
To investigate possible consequences of alterations in the 
coupling between insulin binding and activation of receptor 
kinase for glucose uptake, the cells were exposed to isoprenaline 
(alone or plus adenosine deaminase). These substances c1early 
decreased the coupling efficiency between insulin binding and the 
activation of receptor kinase. Thus isoprenaline had no effect 
on insulin binding (Fig. I), but under the same conditions 
significantly decreased the insulin effect on the activation of 
receptor kinase (Fig. 2). When adenosine deaminase was present 
in addition to isoprenaline, the decrease in the coupling efficiency 
between insulin binding and activation of receptor kinase was 
more pronounced than with isoprenaline alone. 
These alterations in the coupling efficiency between insulin 
binding and activation of receptor kinase induced by isoprenaline 
(alone cr plus adenosine deaminase) were accompanied by a 
decrease in the insulin-sensitivity of glucose uptake. Moreover, 
a quantitative analysis of the data revealed that, although 
isoprenaline (alone or plus adenosine deaminase) altered the 
coupling efficiency between insulin binding and activation of 
receptor kinase, the relationship between receptor-kinase activity 
and glucose uptake (expressed as percentage ofmaximal glucose 
uptake) remained unchanged (Figs. 4a and 4b). Thus a given 
kinase activity corresponded to similar glucose uptake (expressed 
as percentage of maximal uptake), regardless of whether this 
kinase activity was reached in the absence of isoprenaline (alone 
or plus adenosine deaminase), or in their presence together with 
a correspondingly higher insulin concentration, i.e. a higher 
fractional receptor occupancy. These findings indicate that the 
signalling for glucose uptake is more c10sely related to receptor-
kinase activity than to receptor occupancy under these 
conditions. They thus support the hypothesis that insulin-
receptor kinase activity reftects the intracellular signal which 
originates from the insulin receptor and which is transduced to 
the glucose-transport system. Moreover, these data suggest that 
a decreased coupling efficiency between insulin binding and 
activation ofinsulin-receptor kinase results in a decreased insulin-
1991 
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sensitivity of glucose uptake. With regard to the mechanism of 
isoprenaline-induced insulin resistance, our results indicate that 
the decreased insulin-sensitivity of glucose uptake in the presence 
of isoprenaline (alone or plus adenosine deaminase) can be fully 
accounted for by the decreased activation of receptor kinase. 
Although our data suggest that the decrease in insulin-receptor 
kinase activity accounts for the decreased insulin-sensitivity of 
glucose uptake in the presence of isoprenaline (alone or plus 
adenosine deaminase), it is not elear what causes the decrease in 
the maximal glucose uptake (Fig. 3). The most likely explanation 
is that, in addition to its effects on the coupling between insulin 
binding and receptor kinase, isoprenaline has effects on the 
transduction of the insulin signal distal to insulin-receptor 
kinase, or has effects on the glucose-transport system itself. The 
latter notion is supported by studies by James et al. [27], who 
found that isoprenaline induces phosphorylation of the insulin-
regulatable glucose transporter in rat adipocytes. This may 
decrease its intrinsic ability to transport glucose [27,28]. 
Our data on the effects of isoprenaline on insulin binding 
confirm findings by Arsenis & Livingston [12], who found that 
isoprenaline has no effect on insulin binding when a fall in pH 
owing to free fatty acid release is prevented by appropriate assay 
conditions. Only when adenosine deaminase was added in 
addition to isoprenaline did we observe a small decrease in 
insulin binding to the cells. Possibly this was caused by the 
slightly lower pH in the incubation buffer under this condition. 
In any event, this small decrease in insulin binding could not 
explain the decreased insulin effect on receptor-kinase activity. 
The effect of isoprenaline on kinase activity of insulin receptors 
from rat adipocytes has previously been investigated by Häring 
et al. [13] and Arsenis & Livingston [12]. In contrast with our 
present paper, insulin receptors were first isolated and then 
stimulated with insulin in a cell-free system in both studies. 
Changes in the receptor-kinase activity detected by that method 
may not reftect the situation in the intact cell. Our data on the 
effect of isoprenaline on glucose transport are consistent with 
previous reports [12,29-31]. 
The mechanism by which isoprenaline decreases the coupling 
between insulin binding and activation of insulin-receptor kinase 
in intact rat adipocytes is not elear. Previous studies suggest a 
possible role of phosphorylation of serine residues of the insulin 
receptor [14,32,33]. Another possible mechanism in intact cells 
could have been decreased cellular ATP levels, possibly in 
combination with an increased Km for ATP ofthe receptors [13]. 
Chung et al. [34] reported that, in the absence of glucose in the 
incubation buffer, ß-adrenergic agonists extensively deplete ATP 
in rat adipocytes via conversion into cyelic AMP. Under our 
conditions (3 mM-glucose), however, cellular ATP levels were 
decreased by less than 20 % under all conditions tested. 
The observation that in rat adipocytes an increase in receptor-
kinase activity is coupled to an increase in glucose uptake only up 
to a certain point (Figs. 4a and 4b) suggests that there is a 'rate-
limiting step' in the transduction ofthe insulin signal distal to the 
kinase activation. The biochemical basis of this may be a limited 
amount of a signalling compound that is phosphorylated by the 
insulin receptor or interacts with it in some other way in order to 
transmit the insulin signal. Alternatively it is possible that the 
effector systems themselves (like the glucose-transport system) 
can only react to the insulin signal up to a certain intensity. In 
any event, as a consequence of the 'spare' kinase, one would 
expect that a decreased ability of insulin receptors to activate 
their kinase in response to insulin will result in decreased insulin-
sensitivity, rather than a decreased responsiveness, of glucose 
uptake. This notion is supported by our results, which show a 
elose correlation between the effects of isoprenaline (alone or 
plus adenosine deaminase) to decrease the insulin-sensitivity of 
Vol. 274 
glucose uptake and their effects to decrease the coupling efficiency 
between insulin binding and insulin activation of receptor kinase. 
It remains, however, to be established whether a similar 
relationship between the insulin-sensitivity of glucose uptake and 
an altered ability of insulin receptors to activate their kinase in 
response to insulin is also present in pathophysiological states of 
insulin resistance like type-2 diabetes mellitus. 
In summary, we have demonstrated in isolated rat adipocytes 
that, if activation of receptor kinase leads to a stimulation of 
glucose uptake, only 14 % of the maximal kinase activity is 
sufficient for maximal stimulation. Under conditions with 
decreased coupling efficiency between insulin binding and 
activation of receptor kinase, a corresponding decrease in insulin-
sensitivity of glucose uptake was observed. Our data thus lend 
support to the hypothesis that insulin-receptor kinase activity 
reftects the intracellular signal which originates from the insulin 
receptor and which is transduced to the glucose-transport system. 
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